Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum-Reference-Cited by-同舟云学术

Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum

Published:2021-03-04 Issue:5 Volume:17 Page:788-800
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Salvadó Gemma¹²,Milà‐Alomà Marta¹²³⁴,Shekari Mahnaz¹²³,Minguillon Carolina¹²⁴,Fauria Karine¹⁴,Niñerola‐Baizán Aida⁵⁶,Perissinotti Andrés⁵⁶,Kollmorgen Gwendlyn⁷,Buckley Christopher⁸,Farrar Gill⁸,Zetterberg Henrik⁹¹⁰¹¹¹²,Blennow Kaj⁹¹⁰,Suárez‐Calvet Marc¹²⁴¹³,Molinuevo José Luis¹,Gispert Juan Domingo¹²³⁶,

Affiliation:

1. Barcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain

2. IMIM (Hospital del Mar Medical Research Institute) Barcelona Spain

3. Universitat Pompeu Fabra Barcelona Spain

4. Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) Madrid Spain

5. Nuclear Medicine Department Hospital Clínic Barcelona Barcelona Spain

6. Centro de Investigación Biomédica en Red Bioingeniería, Biomateriales y Nanomedicina, (CIBER‐BBN) Barcelona Spain

7. Roche Diagnostics GmbH Penzberg Germany

8. GE Healthcare Life Sciences Amersham UK

9. Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology University of Gothenburg Mölndal Sweden

10. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

11. Department of Neurodegenerative Disease UCL Institute of Neurology Queen Square London UK

12. UK Dementia Research Institute at UCL London UK

13. Servei de Neurologia Hospital del Mar Barcelona Spain

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12245

Reference58 articles.

1. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

2. Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer's disease;Milà‐Alomà M;Ther Adv Neurol Disord,2019

3. Neuroinflammation in Alzheimer's disease

4. Current state of Alzheimer’s fluid biomarkers

5. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease;Alzheimer's & Dementia;2024-07-19

2. Time‐encoded ASL reveals lower cerebral blood flow in the early AD continuum;Alzheimer's & Dementia;2024-07-03

3. Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology;2024-06-13

4. Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression;Alzheimer's & Dementia;2023-09-10

5. Revealing the Mechanisms of Byu dMar 25 in the Treatment of Alzheimer’s Disease through Network Pharmacology, Molecular Docking, and In Vivo Experiment;ACS Omega;2023-06-13